{"id":255052,"date":"2023-11-06T10:22:23","date_gmt":"2023-11-06T15:22:23","guid":{"rendered":"https:\/\/platohealth.ai\/cloud-in-medical-devices-qa-with-globaldata-thematic-analyst\/"},"modified":"2023-11-06T18:09:22","modified_gmt":"2023-11-06T23:09:22","slug":"cloud-in-medical-devices-qa-with-globaldata-thematic-analyst","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/cloud-in-medical-devices-qa-with-globaldata-thematic-analyst\/","title":{"rendered":"Cloud in medical devices: Q&A with GlobalData thematic analyst","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

<\/p>\n

\n
\n
<\/div>
Cloud computing can help medical device companies to facilitate device recall and meet industry requirements. Credit: Shutterstock<\/figcaption><\/figure>\n<\/div>\n

<\/p>\n

Jemima Walker is an associate analyst in GlobalData\u2019s Thematic Intelligence team. Her expertise lies in the healthcare industry and in themes including cloud, robotics, ecommerce, healthtech, and cybersecurity.\u202f\u202f\u202f <\/em><\/p>\n

Lara Virrey: What are the biggest challenges facing medical devices companies today?\u202f\u202f\u202f <\/h3>\n

Jemima Walker:<\/strong> Two of the biggest challenges facing the medical device industry today would include regulation and supply chain disruption.\u202fMedical device companies are under some of the strictest data privacy regulations worldwide. Alongside strict data privacy regulations such as the US Health Insurance Portability and Accountability Act (HIPAA), medical device manufacturers must comply with further rules to ensure the safety and performance of medical devices in any country in which they operate.  <\/p>\n

Each country and each region has different regulatory rules for tracking medical devices and facilitating recalls in the event of a fault, such as the US Unique Device Identification (UDI) system, the European Medical Device Regulation (MDR) system, and the China Medical Device Product Registration (CMDR) system.\u202f\u202f <\/p>\n

Medical device companies supply chains can be inefficient and vulnerable to infrastructure and performance issues. The Covid-19 pandemic exposed many of these vulnerabilities, leading to widespread disruptions in supply.  <\/p>\n

Companies had to fulfil staggering demand, prevent manufacturing delays, and manage supply chain bottlenecks while ensuring products were kept in strictly regulated environments. Supply chain disruption will continue as many countries with larger manufacturing capabilities (e.g., China) continue to battle waves of Covid-19 infections.  <\/p>\n

High demand will likely continue as populations grow, particularly in countries with reduced supply chain infrastructure. To prevent the reduced availability of medicines and medical devices due to supply chain disruption medical device manufacturers must invest in supply chain technologies to move products from production to end users without delay.\u202f <\/p>\n

\n

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.<\/p>\n